mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.006 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
0.007 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.009 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |